ConductScience.org, home

Paper40573239

Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.

Salem D and 9 others. Pharmaceuticals (Basel), 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes. Papers, record 40573239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40573239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.29, provisional
iCite
Revised in PubMed
2025-10-19
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salem DDina
2Abdel-Ghany SShaimaahttps://orcid.org/0000-0002-3883-2000
3Mohamed EEman
4Alahmady NFNada Fhttps://orcid.org/0000-0002-6203-2070
5Alqosaibi AAmanyhttps://orcid.org/0000-0001-8348-9451
6Al-Dhuayan ISIbtesam Shttps://orcid.org/0000-0001-6910-0534
7Alnamshan MMMashael Mashal
8Arneth RRebekka
9Arneth BBorroshttps://orcid.org/0000-0002-9793-0970
10Sabit HHusseinhttps://orcid.org/0000-0001-9021-8334

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136519808Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications.J Extracell Vesicles2022https://conductscience.org/library/papers/36519808PubMed
238884850A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer.Drug Deliv Transl Res2025https://conductscience.org/library/papers/38884850PubMed
335804089Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity.Sci Rep2022https://conductscience.org/library/papers/35804089PubMed
434930289Aloe derived nanovesicle as a functional carrier for indocyanine green encapsulation and phototherapy.J Nanobiotechnology2021https://conductscience.org/library/papers/34930289PubMed
534496230Exosomes as mediators of intercellular crosstalk in metabolism.Cell Metab2021https://conductscience.org/library/papers/34496230PubMed
635209221Synthesis of Copper Oxide-Based Nanoformulations of Etoricoxib and Montelukast and Their Evaluation through Analgesic, Anti-Inflammatory, Anti-Pyretic, and Acute Toxicity Activities.Molecules2022https://conductscience.org/library/papers/35209221PubMed
734685596Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications.Cells2021https://conductscience.org/library/papers/34685596PubMed
836528193Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.J Control Release2023https://conductscience.org/library/papers/36528193PubMed
911134944Crystallization of the yeast elongation factor complex eEF1A-eEF1B alpha.Acta Crystallogr D Biol Crystallogr2001https://conductscience.org/library/papers/11134944PubMed
1035260831Challenges and directions in studying cell-cell communication by extracellular vesicles.Nat Rev Mol Cell Biol2022https://conductscience.org/library/papers/35260831PubMed
1116618135Adhesion of antibody-functionalized polymersomes.Langmuir2006https://conductscience.org/library/papers/16618135PubMed
1230359033Apple-Derived Nanoparticles Modulate Expression of Organic-Anion-Transporting Polypeptide (OATP) 2B1 in Caco-2 Cells.Mol Pharm2018https://conductscience.org/library/papers/30359033PubMed
1326098775Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death.Oncotarget2015https://conductscience.org/library/papers/26098775PubMed
1427318094Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.Biomaterials2016https://conductscience.org/library/papers/27318094PubMed
1538059133Exosomes: Mediators of cellular communication in potentially malignant oral lesions and head and neck cancers.F1000Res2023https://conductscience.org/library/papers/38059133PubMed
1636733407Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis.Int J Nanomedicine2023https://conductscience.org/library/papers/36733407PubMed
1734151426Plant-derived exosome-like nanoparticles: A concise review on its extraction methods, content, bioactivities, and potential as functional food ingredient.J Food Sci2021https://conductscience.org/library/papers/34151426PubMed
1836196516Drug Value of Drynariae Rhizoma Root-Derived Extracellular Vesicles for Neurodegenerative Diseases Based on Proteomics and Bioinformatics.Plant Signal Behav2022https://conductscience.org/library/papers/36196516PubMed
1934656117Extracellular vesicles: mediators of intercellular communication in tissue injury and disease.Cell Commun Signal2021https://conductscience.org/library/papers/34656117PubMed
2034381015Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients.Signal Transduct Target Ther2021https://conductscience.org/library/papers/34381015PubMed

See all 50 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42793979Fruit- and Vegetable-Derived Exosome-like Nanovesicles: A Review.Foods2026https://conductscience.org/library/papers/42793979PubMed
42371419Plant-derived extracellular vesicles for drug delivery: current and future.Regen Biomater2026https://conductscience.org/library/papers/42371419PubMed
42347955Unveiling the antifungal arsenal: proteomic profiling of tomato exosomes.Planta2026https://conductscience.org/library/papers/42347955PubMed
42292037Plant-Derived Exosome-Like Nanoparticles in Neurodegenerative Diseases: From Dual Bioactive-Delivery Roles to Translational Challenges.Int J Nanomedicine2026https://conductscience.org/library/papers/42292037PubMed
42014584Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations.Pharm Res2026https://conductscience.org/library/papers/42014584PubMed
41471741Comparative Analysis of the Composition of Exosome-like Nanoparticles from Dried and Fresh Portulaca oleracea L.Molecules2025https://conductscience.org/library/papers/41471741PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40573239

GET https://conductscience.org/api/papers/v1/40573239/references?page=2